BNY Mellon Global Real Return Fund LSE:AZN Holdings History
BNY Mellon Global Real Return Fund's AstraZeneca PLC Holding Summary
As of 2025-04-30, BNY Mellon Advantage Funds, Inc. held 78,385.00 shares of AstraZeneca PLC(LSE:AZN), totaling £11.21 Mil. This investment constitutes 3.48% of their stock portfolio, and BNY Mellon Advantage Funds, Inc. now holds 0.01% of the outstanding AstraZeneca PLC(LSE:AZN) stock.
The initial trade took place in 2021Q1. And since then BNY Mellon Global Real Return Fund has made 7 purchases of LSE:AZN, at an average price of £79.06, for a total of 586,325.00 shares. In addition, there have been 10 sales at an average price of £105.95 for 507,940.00 shares. Based on historical transaction data and LSE:AZN's current price of £102.18, BNY Mellon Global Real Return Fund's estimated gain on his LSE:AZN holdings is £15.47 Mil, reflecting a 33.38% gain to date.
BNY Mellon Global Real Return Fund LSE:AZN (£102.18) Holding Chart
BNY Mellon Global Real Return Fund LSE:AZN (£102.18) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price £-/Share | ||
| Shares Sold | 0 | Average Price £-/Share | ||
| Current Price £0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
